Literature DB >> 10492488

Stability of cefepime in peritoneal dialysis solution.

J C Williamson1, D F Volles, P L Lynch, P D Rogers, D M Haverstick.   

Abstract

OBJECTIVE: To determine the stability of cefepime in peritoneal dialysis solution.
DESIGN: Cefepime HCl was added to premade bags of Delflex peritoneal dialysis solution with 1.5% dextrose to produce a cefepime concentration of approximately 100 microg/mL. Peritoneal dialysis solution bags were stored at 4, 25, and 37 degrees C to simulate refrigeration, room temperature, and body temperature, respectively. Samples were drawn at scheduled times up to 336, 168, and 48 hours, respectively, after the addition of cefepime HCl. Cefepime concentrations were measured by HPLC.
SETTING: This study was performed at a university-affiliated tertiary care hospital. OUTCOME MEASURE: If the mean concentration of the samples at a given time and condition was >90% of the initial concentration, cefepime was considered stable at that time and condition.
RESULTS: The mean HPLC results for samples drawn at each time and condition were all >90%.
CONCLUSIONS: Cefepime is stable in peritoneal dialysis solution with dextrose 1.5% for 14 days refrigerated, seven days at room temperature, and 48 hours at 37 degrees C.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492488     DOI: 10.1345/aph.18336

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  3 in total

Review 1.  Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.

Authors:  Bradley A Warady; Sevcan Bakkaloglu; Jason Newland; Michelle Cantwell; Enrico Verrina; Alicia Neu; Vimal Chadha; Hui-Kim Yap; Franz Schaefer
Journal:  Perit Dial Int       Date:  2012-06       Impact factor: 1.756

2.  Stability and antibacterial activity of cefepime during continuous infusion.

Authors:  Pål F Sprauten; Paul M Beringer; Stan G Louie; Timothy W Synold; Mark A Gill
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 3.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.